We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$3.06B
AUM Growth
-$59.7M
Cap. Flow
-$149M
Cap. Flow %
-4.86%
Top 10 Hldgs %
25.7%
Holding
170
New
5
Increased
22
Reduced
51
Closed
8

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$1.24M
2
BMY icon
Bristol-Myers Squibb
BMY
+$895K
3
EW icon
Edwards Lifesciences
EW
+$791K
4
VFC icon
VF Corp
VFC
+$432K
5
NVO
Novo Nordisk
NVO
+$238K

Top Sells

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$29.5M
2
INFY icon
Infosys
INFY
+$20.2M
3
ESRX
Express Scripts Holding Company
ESRX
+$18.7M
4
AMGN icon
Amgen
AMGN
+$16.9M
5
POT
Potash Corp Of Saskatchewan
POT
+$12M

Sector Composition

Rank Sector Weight
1 Technology 24.45%
2 Healthcare 21.61%
3 Industrials 20.47%
4 Consumer Staples 15.98%
5 Consumer Discretionary 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESRX
51
DELISTED
Express Scripts Holding Company
ESRX
$28.6M 0.93%
405,532
-250,000
-38% -$18.7M
INTC icon
52
Intel
INTC
$466B
$26.9M 0.88%
711,350
– –
PX
53
DELISTED
Praxair Inc
PX
$26.7M 0.87%
221,225
– –
ORCL icon
54
Oracle
ORCL
$331B
$26.3M 0.86%
670,728
+101
+0% +$4.12K
RTX icon
55
RTX Corp
RTX
$287B
$25.5M 0.83%
398,636
– –
FAST icon
56
Fastenal
FAST
$54B
$25.1M 0.82%
2,407,840
– –
LECO icon
57
Lincoln Electric
LECO
$13.8B
$25.1M 0.82%
401,200
– –
SJM icon
58
J.M. Smucker
SJM
$12.6B
$25.1M 0.82%
185,000
– –
ABBV icon
59
AbbVie
ABBV
$458B
$24.2M 0.79%
383,561
– –
IT icon
60
Gartner
IT
$9.41B
$22.2M 0.73%
251,441
– –
CELG
61
DELISTED
Celgene Corp
CELG
$21.8M 0.71%
209,000
+2,000
+1% +$216K
JCI icon
62
Johnson Controls International
JCI
$87.5B
$20.3M 0.66%
437,341
-61,960
-12% -$2.87M
UL icon
63
Unilever
UL
$131B
$20.2M 0.66%
378,400
– –
ABT icon
64
Abbott
ABT
$180B
$18.6M 0.61%
439,945
+28,912
+7% +$1.24M
GWW icon
65
W.W. Grainger
GWW
$65.3B
$18.4M 0.6%
81,650
– –
PSX icon
66
Phillips 66
PSX
$82.9B
$18M 0.59%
223,747
– –
GSK icon
67
GSK
GSK
$103B
$17.8M 0.58%
330,760
-800
-0.2% -$43.9K
XRAY icon
68
Dentsply Sirona
XRAY
$2.59B
$16.3M 0.53%
275,000
– –
PG icon
69
Procter & Gamble
PG
$343B
$14.6M 0.48%
162,907
+2,000
+1% +$174K
KEYS icon
70
Keysight
KEYS
$54.5B
$14.4M 0.47%
455,094
– –
CVG
71
DELISTED
Convergys
CVG
$13.7M 0.45%
451,733
-60,000
-12% -$1.7M
SWK icon
72
Stanley Black & Decker
SWK
$14.2B
$13.6M 0.44%
110,434
– –
RPM icon
73
RPM International
RPM
$13.7B
$11.2M 0.37%
208,356
– –
MEOH icon
74
Methanex
MEOH
$4.32B
$10.9M 0.36%
305,000
+5,000
+2% +$147K
INFY icon
75
Infosys
INFY
$45B
$6.31M 0.21%
800,000
-2,456,000
-75% -$20.2M
1 2
3
4 5

Similar funds

FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $7.06B AUM 28.93% 1-Year Est. Return

Saturna Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Saturna Capital held 170 positions worth $3.06B, down 1.9% from $3.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Saturna Capital withdrew a net $149M in Q3 2016, closing 8 positions and reducing 51 holdings. Its most notable exit was Gentex, an estimated $4.79M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Saturna Capital opened a new position in Edwards Lifesciences worth $844K.

  • Saturna Capital's largest Q3 2016 buy was Edwards Lifesciences: 21,000 shares worth $844K.
  • Saturna Capital added most to Abbott in Q3 2016, an estimated $1.24M increase.
  • Saturna Capital's biggest Q3 2016 reduction was Akamai, cutting an estimated $29.5M.
  • Saturna Capital fully exited Gentex in Q3 2016, selling an estimated $4.79M.
  • Saturna Capital's ten largest holdings make up 26% of its $3.06B portfolio in Q3 2016.
  • Saturna Capital opened 5 new positions and closed 8 in Q3 2016.
  • Saturna Capital's portfolio value fell 1.9% quarter-over-quarter to $3.06B.

Based on Saturna Capital's 13F filing for Q3 2016, filed 14 Nov 2016.